Female doctors have taken on extra—often unpaid—work during the pandemic, to the detriment of their own wellbeing and […]
Month: March 2021
Organising the covid-19 vaccination programme puts enormous pressure on healthcare systems. Two major challenges must be tackled for […]
A large private provider of mental health services tried to discourage a psychiatrist from telling a coroner that […]
The precise combination of factors responsible for the disproportionate effect of covid-19 on ethnic minority groups is likely […]
NHS England has agreed a deal to ensure that Zolgensma (onasemnogene abeparvovec), a one-off gene therapy medicine, will […]
Gilead’s CAR-T med Yescarta gets a leg up on Novartis rival with FDA nod in follicular lymphoma esagonowsky […]
GlaxoSmithKline’s doctor payments double as relaxed policy plays out bbulik Mon, 03/08/2021 – 10:10
Manufacturing roundup—Moderna taps Baxter for COVID shot production; AGC, WuXi AppTec grow cell and gene therapy ambitions; Prestige […]
Novartis’ £1.79M gene therapy Zolgensma scores cost watchdog’s backing, threatening Biogen’s Spinraza esagonowsky Mon, 03/08/2021 – 09:16
Roche joins the FDA accelerated approval revamp team, nixing a Tecentriq bladder cancer nod aliu Mon, 03/08/2021 – […]